Overall, our findings suggest that secretory mucin MUC5AC has a tumor promoting role via the transmembrane protein CD44 and confers chemoresistance via the β-catenin/p53/p21 signaling pathway in CRC (Fig. 7e). The gene discussed is TP53; the disease is neoplasm.